Philips Battles To Provide More Information, But Not At The Cost Of Burnout
Executive Summary
As medicine is increasingly reliant on medical imaging, Royal Philips hopes its artificial intelligence-bolstered imaging systems align with the demand for more information while overcoming the fear of radiologist burnout.
You may also be interested in...
Advancing The Precision Mission At RSNA 2020
RSNA is the next major global medtech event to be run under a virtual format this fall. Under COVID-19, the major medtechs are finding different ways to demonstrate value, as Royal Philips explains.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
Moving Pharma Execs Out Of The Shadows Is Key To Building Public Trust
2024 Rising Leader, Jack O’Meara, says the industry must ‘promote personalities’ when building new biotech businesses to gain the trust of investors and the public.